Rosiswayar kasusuwa ta kasusuwa cuta ce mai saurin ciwan ƙwayoyin cuta na ƙwayoyin cuta. Suna fa'ida daga magungunan hana JAK2: saukaka alamomi, rayuwa mai tsawo, da ingantaccen rayuwa. Koyaya, shekaru biyu ko uku bayan fara jiyya, wasu marasa lafiya suna haɓaka m lymphoma B-cell. A cikin haɗin gwiwa tare da masu bincike a Vienna, MedUni da Vetmeduni, masu hana JAK2 sun farka "dormant" lymphoma da ciwon daji a cikin ɓacin kashi a karon farko.
Yin amfani da biopsy na kasusuwa a farkon cutar, 16% na marasa lafiya tare da myelofibrosis an gano cewa suna da lymphoma mai tsanani. A cikin kusan 6% na waɗannan marasa lafiya, lokacin da aka motsa su tare da masu hana JAK2, ya fashe. A cewar masu ilimin halittar jini, idan aka yi amfani da dabarun nazarin halittu masu mahimmanci don neman latent lymphoma na rayayye, yana yiwuwa a gano lymphoma na barci. Wannan shine mafi kyawun kayan aikin tsinkaya wanda ke ba mu damar bincika 16% na marasa lafiya da aka gano a matsayin marasa lafiya masu haɗari kafin jiyya tare da masu hana JAK2.
An tabbatar da shi a cikin samfurin linzamin kwamfuta cewa berayen da aka yiwa daskarewa da hagu kuma sun sami lymphoma. Hadin gwiwar bangarori da yawa misali ne mai kyau na yadda bincike ya kasance a bayyane kuma mahimmancin musayar bayanai a likitanci. Mataki na gaba: tarin lamura na ƙasa da ƙasa da bayanan da suka danganci sun fara inganta lafiyar kwayoyi, kuma masu bincike suna aiki tare da kamfanonin magani waɗanda ke samar da waɗannan ƙwayoyin magani. Kafa wata gada mai sauri, ingantacciya da taɓarɓarewa tsakanin ƙirar linzamin kwamfuta da binciken asibiti, daidai haɗuwa da bincike na asali, ƙaddara da aikin asibiti don fa'idantar da masu cutar kansa.
